BioMarin Pharmaceutical
BMRN
#1730
Rank
NZ$21.59 B
Marketcap
NZ$111.57
Share price
-1.45%
Change (1 day)
11.78%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2026 (TTM): NZ$0.64 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are NZ$3.24 Billion. In 2025 the company made an earning of NZ$0.80 Billion a decrease over its 2024 earnings that were of NZ$0.90 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.64 B-20.46%
2025 NZ$0.80 B-10.94%
2024 NZ$0.90 B187.31%
2023 NZ$0.31 B26.07%
2022 NZ$0.25 B-298.51%
2021 -NZ$0.13 Billion78.04%
2020 -NZ$70.8 Million-55.36%
2019 -NZ$0.16 Billion-33.56%
2018 -NZ$0.24 Billion297.78%
2017 -NZ$60.01 Million-95.68%
2016 -NZ$1.4 Billion437.12%
2015 -NZ$0.26 Billion23.91%
2014 -NZ$0.21 Billion-29.25%
2013 -NZ$0.3 Billion49.23%
2012 -NZ$0.2 Billion171.11%
2011 -NZ$72.98 Million103.01%
2010 -NZ$35.95 Million-3903.54%
2009 NZ$0.94 M-98.31%
2008 NZ$55.9 M-189.7%
2007 -NZ$62.33 Million51.02%
2006 -NZ$41.28 Million-61.58%
2005 -NZ$0.11 Billion-56.59%
2004 -NZ$0.25 Billion95.13%
2003 -NZ$0.13 Billion12.09%
2002 -NZ$0.12 Billion73.19%
2001 -NZ$65.32 Million18.32%
2000 -NZ$55.21 Million19.65%
1999 -NZ$46.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
NZ$12.81 B 1,886.15%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-NZ$0.9 Billion-239.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.19 Billion-128.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.13 B-79.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.31 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$0.49 B-23.12%๐Ÿ‡บ๐Ÿ‡ธ USA